Eason M G, Jacinto M T, Theiss C T, Liggett S B
Department of Medicine (Pulmonary), University of Cincinnati College of Medicine, OH 45267-0564.
Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11178-82. doi: 10.1073/pnas.91.23.11178.
Most guanine nucleotide binding protein (G protein)-coupled receptors have a conserved cysteine in the C-terminal cytoplasmic tail near the seventh transmembrane spanning region. This cysteine is known to be palmitoylated in rhodopsin, the beta 2-adrenergic receptor (beta 2AR) and the alpha 2A-adrenergic receptor (alpha 2AAR). For the beta 2AR, this cysteine has been shown to be important for stimulatory G protein (Gs) coupling and agonist-promoted desensitization. For the alpha 2AAR (human alpha 2 C10) palmitoylation occurs at Cys-442, but it is not known what function such fatty acid acylation subserves. The closely related alpha 2CAR subtype denoted alpha 2C4 lacks a cysteine in this region and has different G-protein-coupling characteristics and agonist regulatory properties as compared to alpha 2C10. To assess the role of the palmitoylcysteine in alpha 2AR function, we constructed a mutated alpha 2C10 having a phenylalanine (the analogous amino acid in the alpha 2C4 in this position) substituted for Cys-442, denoted alpha 2C10(Phe-442), and expressed this along with wild-type alpha 2C10 and alpha 2C4 in CHO cells. Functional coupling to inhibitory G protein (Gi) and to Gs was identical between wild-type alpha 2C10 and alpha 2C10(Phe-442). Agonist-promoted desensitization of both the Gi and Gs-mediated pathways was also found to be unaffected by this mutation. Cellular trafficking induced by agonist exposure was evaluated by delineation of intracellular (sequestered) versus cell surface receptors and by determination of net receptor loss. Mutation of Cys-442 did not alter the extent or rate of agonist-promoted sequestration induced by agonists or the recovery from sequestration. However, the downregulation of receptor number after prolonged agonist exposure was completely abolished by this mutation and converted alpha 2C10 to an alpha 2C4 phenotype in regard to this adaptive response. Another mutated alpha 2C10, in which Cys-442 was replaced by alanine, also failed to downregulate. Thus, the function of this cytoplasmic palmitoylcysteine is distinctly different between the alpha 2AR and other G-protein-coupled receptors such as the beta 2AR and rhodopsin, and this suggests that this molecular attribute may subserve diverse roles among members of this family of receptors. For the alpha 2ARs, this may represent an evolved feature that provides for differing needs for regulation of the alpha 2C10 and alpha 2C4 subtypes by agonist.
大多数鸟嘌呤核苷酸结合蛋白(G蛋白)偶联受体在靠近第七个跨膜区的C末端胞质尾巴中有一个保守的半胱氨酸。已知视紫红质、β2肾上腺素能受体(β2AR)和α2A肾上腺素能受体(α2AAR)中的这个半胱氨酸会被棕榈酰化。对于β2AR,已证明这个半胱氨酸对刺激性G蛋白(Gs)偶联和激动剂促进的脱敏很重要。对于α2AAR(人α2C10),棕榈酰化发生在Cys-442,但尚不清楚这种脂肪酸酰化有什么功能。与之密切相关的α2CAR亚型α2C4在该区域缺乏半胱氨酸,与α2C10相比,具有不同的G蛋白偶联特性和激动剂调节特性。为了评估棕榈酰半胱氨酸在α2AR功能中的作用,我们构建了一个突变的α2C10,用苯丙氨酸(该位置α2C4中的类似氨基酸)取代Cys-442,命名为α2C10(Phe-442),并在CHO细胞中与野生型α2C10和α2C4一起表达。野生型α2C10和α2C10(Phe-442)与抑制性G蛋白(Gi)和Gs的功能偶联相同。还发现该突变不影响Gi和Gs介导的途径的激动剂促进的脱敏。通过描绘细胞内(隔离)与细胞表面受体以及通过测定净受体损失来评估激动剂暴露诱导的细胞转运。Cys-442的突变没有改变激动剂诱导的激动剂促进的隔离程度或速率,也没有改变从隔离状态恢复的情况。然而,长时间激动剂暴露后受体数量的下调被该突变完全消除,并且就这种适应性反应而言,α2C10转变为α2C4表型。另一个将Cys-442替换为丙氨酸的突变α2C10也未能下调。因此,这种胞质棕榈酰半胱氨酸在α2AR和其他G蛋白偶联受体(如β2AR和视紫红质)中的功能明显不同,这表明这种分子特性可能在该受体家族成员中发挥不同的作用。对于α2ARs,这可能代表一种进化特征,为激动剂对α2C10和α2C4亚型的不同调节需求提供支持。